Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.

Not Applicable

Completed

• Conditions: Idiopathic Epiretinal Membrane, Cataract

• Registration Number: NCT00376857
• Lead Sponsor: University of Regensburg

Brief Summary

It was the aim of the present study to prospectively compare the functional and morphological outcome of idiopathic epiretinal membrane surgery with and without the assistance of Indocyanine green (ICG). The main outcome measure was improvement of best-corrected visual acuity (BCVA). This was treated as an open question and we had no hypothesis which of the two therapies was superior.

Detailed Description

Not available

Study Timeline

• Status Verified: 2006-09
• Study First Submitted: 2006-09-13
• Study First Submitted QC: 2006-09-13
• Last Update Submitted: 2006-09-13
• Study First Posted: 2006-09-15
• Last Update Posted: 2006-09-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients with IEM and cataract or posterior chamber intraocular lens pseudophakia complaining of loss of visual acuity and metamorphopsia during the past six months.

Read More

Exclusion Criteria

• Other retinal disease, non-idiopathic epiretinal membrane, glaucoma or history of retinal detachment.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
The main outcome measure was improvement of best-corrected visual acuity (BCVA).

Secondary Outcome Measures

Name	Time	Method
Other outcome measures included postoperative BCVA, status of Amsler grid test, reduction of macular retinal thickness, residual or recurrent macular epiretinal membrane

Trial Locations

Locations (1)

Dept. of Ophthalmology, University of Regensburg; 🇩🇪 Regensburg, Germany